Lexeo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Otero Jose Manuel
Lexeo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Robertson Jenny
Lexeo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer See Tai Sandi
Lexeo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Townsend Richard Nolan
Lexeo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Robertson Jenny
Lexeo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Adler Eric
Lexeo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer See Tai Sandi
Lexeo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Townsend Richard Nolan
Lexeo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rasbach Kyle
Lexeo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Adler Eric
Lexeo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer See Tai Sandi
Lexeo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Robertson Jenny
Lexeo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Otero Jose Manuel
Lexeo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Townsend Richard Nolan
Lexeo Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Rasbach Kyle
Lexeo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Townsend Richard Nolan
Lexeo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director CHOLMONDELEY PAULA H
Lexeo Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lundbeckfond Invest A/S(2.9%),Lene Skole(2.9%)
Lexeo Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Longitude Capital Partners IV, LLC(8.4%),Longitude Venture Partners IV, L.P.(8.4%), etc.
Lexeo Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Janus Henderson Group plc(11.4%),Janus Henderson Biotech Innovation Master Fund Ltd(5.7%)